Jump to main content
Jump to site search
Access to RSC content Close the message box

Continue to access RSC content when you are not at your institution. Follow our step-by-step guide.


Issue 83, 2013
Previous Article Next Article

Covalent modification of cell surfaces with TLR agonists improves & directs immune stimulation

Author affiliations

Abstract

We present a primary example of a cell surface modified with a synergistic combination of agonists to tune immune stimulation. A model cell line, Lewis Lung Carcinoma, was covalently modified with CpG-oligonucleotides and lipoteichoic acid, both Toll-like receptor (TLR) agonists. The immune-stimulating constructs provided greater stimulation of NF-κB in a model cell line and bone marrow-derived dendritic cells than the components unconjugated in solution.

Graphical abstract: Covalent modification of cell surfaces with TLR agonists improves & directs immune stimulation

Back to tab navigation

Supplementary files

Article information


Submitted
19 Jul 2013
Accepted
26 Aug 2013
First published
27 Aug 2013

Chem. Commun., 2013,49, 9618-9620
Article type
Communication

Covalent modification of cell surfaces with TLR agonists improves & directs immune stimulation

J. K. Tom, R. J. Mancini and A. P. Esser-Kahn, Chem. Commun., 2013, 49, 9618
DOI: 10.1039/C3CC45468A

Social activity

Search articles by author

Spotlight

Advertisements